Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study

4

punsarn.item.page.citation

Sitthideatphaiboon P., Reungwetwattana T., Jaruhathai S., Supavavej A., Limpawittayakul P., Maneenil K., Korphaisarn K., Suksombooncharoen T., Thongthieang L., Sathitruangsak C., Chayangsu C., Ratanabunjerdkul H., Prasongsook N., Sriuranpong V. Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study. Frontiers in Oncology Vol.15 (2025). doi:10.3389/fonc.2025.1647385 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/113093

item.page.availability

Collections